Cannapharmarx Stock Market Value
| CPMD Stock | USD 0 0.0006 16.67% |
| Symbol | CannaPharmaRx |
CannaPharmaRx 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CannaPharmaRx's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CannaPharmaRx.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in CannaPharmaRx on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding CannaPharmaRx or generate 0.0% return on investment in CannaPharmaRx over 90 days. CannaPharmaRx is related to or competes with Unidoc Health, and Devonian Health. CannaPharmaRX, Inc. operates in the cannabis industry in Canada More
CannaPharmaRx Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CannaPharmaRx's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CannaPharmaRx upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 16.01 | |||
| Information Ratio | 0.084 | |||
| Maximum Drawdown | 105.68 | |||
| Value At Risk | (20.75) | |||
| Potential Upside | 28.57 |
CannaPharmaRx Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CannaPharmaRx's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CannaPharmaRx's standard deviation. In reality, there are many statistical measures that can use CannaPharmaRx historical prices to predict the future CannaPharmaRx's volatility.| Risk Adjusted Performance | 0.0787 | |||
| Jensen Alpha | 1.46 | |||
| Total Risk Alpha | 0.5716 | |||
| Sortino Ratio | 0.0928 | |||
| Treynor Ratio | 0.9678 |
CannaPharmaRx February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0787 | |||
| Market Risk Adjusted Performance | 0.9778 | |||
| Mean Deviation | 9.37 | |||
| Semi Deviation | 9.79 | |||
| Downside Deviation | 16.01 | |||
| Coefficient Of Variation | 1149.32 | |||
| Standard Deviation | 17.7 | |||
| Variance | 313.13 | |||
| Information Ratio | 0.084 | |||
| Jensen Alpha | 1.46 | |||
| Total Risk Alpha | 0.5716 | |||
| Sortino Ratio | 0.0928 | |||
| Treynor Ratio | 0.9678 | |||
| Maximum Drawdown | 105.68 | |||
| Value At Risk | (20.75) | |||
| Potential Upside | 28.57 | |||
| Downside Variance | 256.38 | |||
| Semi Variance | 95.85 | |||
| Expected Short fall | (22.16) | |||
| Skewness | 2.17 | |||
| Kurtosis | 9.19 |
CannaPharmaRx Backtested Returns
CannaPharmaRx appears to be out of control, given 3 months investment horizon. CannaPharmaRx secures Sharpe Ratio (or Efficiency) of 0.0312, which signifies that the company had a 0.0312 % return per unit of risk over the last 3 months. By analyzing CannaPharmaRx's technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please makes use of CannaPharmaRx's Downside Deviation of 16.01, mean deviation of 9.37, and Risk Adjusted Performance of 0.0787 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, CannaPharmaRx holds a performance score of 2. The firm shows a Beta (market volatility) of 1.58, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CannaPharmaRx will likely underperform. Please check CannaPharmaRx's downside variance, day median price, and the relationship between the maximum drawdown and skewness , to make a quick decision on whether CannaPharmaRx's price patterns will revert.
Auto-correlation | -0.32 |
Poor reverse predictability
CannaPharmaRx has poor reverse predictability. Overlapping area represents the amount of predictability between CannaPharmaRx time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CannaPharmaRx price movement. The serial correlation of -0.32 indicates that nearly 32.0% of current CannaPharmaRx price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.32 | |
| Spearman Rank Test | -0.79 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in CannaPharmaRx Pink Sheet
CannaPharmaRx financial ratios help investors to determine whether CannaPharmaRx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CannaPharmaRx with respect to the benefits of owning CannaPharmaRx security.